Taurine attenuates acute hyperglycaemia-induced endothelial cell apoptosis, leucocyte-endothelial cell interactions and cardiac dysfunction

Journal of Vascular Research

Volumn 44, Issue 1, 2007, Pages 31-39

  Casey, Rowan G ^a,b   Gang, Chen ^a   Joyce, Myles ^a   Bouchier Hayes, David J ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b Toberbawn   (Ireland)

Author keywords

Blood pressure; Diabetes; Haemodynamics; Hypertension; Receptors

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; TAURINE; TROPONIN T;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD PRESSURE; CELL INTERACTION; CONTROLLED STUDY; EDEMA; ENDOTHELIUM CELL; HEART DISEASE; HYPERGLYCEMIA; LEUKOCYTE; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; LEUKOCYTE ROLLING; MALE; MESENTERIC VEIN; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULSE RATE; RAT; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ANIMALS; APOPTOSIS; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CELL ADHESION; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GLUCOSE; HYPERGLYCEMIA; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTE ROLLING; LEUKOCYTES; MALE; PULSE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TAURINE; TIME FACTORS; TROPONIN T; VENULES;

EID: 33846315460     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097893     Document Type: Article

References (48)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
2. Lorenzi M, Cagliero E, Toledo S: Glucose toxicity for human endothelial cells in culture: delayed replication, disturbed cell cycle, and accelerated death. Diabetes 1985;34:621-627.
3. 2 in high glucose medium. Diabetes 1995;44:520-526.
4. 2 in human umbilical vein endothelial cells cultured in high glucose medium. Diabetologia 1994;37:264-269.
5. Wu QD, Wang JH, Fennessy F, Redmond HP, Bouchier-Hayes D: Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis. Am J Physiol 1999;46:1229-1238.
6. Kimura C, Oike M, Koyama T, Ito Y: Impairment of endothelial nitric oxide production by acute glucose overload. Am J Physiol 2001;280:171-178.
7. Porte D, Schwartz M: Diabetes complications: why is glucose potentially toxic? Science 1996;272:699-700.
8. Schäffler A, Arndt H, Schölmerich J, Palitzsch KD: Acute hyperglycaemia causes severe disturbances of mesenteric microcirculation in an in vivo rat model. Eur J Clin Invest 1998;28:886-893.
9. Dolgov VV, Zaikina E, Bondarenko MF, Repin VS: Aortic endothelium of alloxan diabetic rabbits: a quantitative study using scanning electron microscopy. Diabetologia 1982;22:338-343.
10. Davies MG, Hagen PO: The vascular endothelium: a new horizon. Ann Surg 1993;218:593-609.
11. Granger DN, Benoit JN, Suzuki M, Grisham MB: Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am J Physiol 1989;257:683-688.
12. Weiss SJ: Tissue destruction by neutrophils. New Engl J Med 1989;320:365-376.
13. Mehta JL, Li DY: Inflammation in ischemic heart disease: response to tissue injury or a pathogenetic villain? Cardiovasc Res 1999;43:291-299.
14. Lefer BJ, Lefer AM: Nitric oxide homeostasis control as therapy for cardiovascular diseases. Cardiovasc Res 1993;27:2282.
15. Crow JP, Beckman JS: Reactions between nitric oxide, superoxide and peroxynitrite: footprints of peroxynitrite in vivo. Adv Pharmacol 1995;34:17-43.
16. Ceriello A, Quagliaro L, D'Amico M, Di Filippo C, Marfella R, Nappo F, Berrino L, Rossi F, Giugliano D: Acute hyperglycaemia induced nitrotyrosine formation and apoptosis in perfused heart from rats. Diabetes 2002;51:1076-1082.
17. Fiordaliso F, Leri A, Cesselli D, Limana F, Safai B, Nadal-Ginard B, Anversa P, Kajstura J: Hyperglycaemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 2001;50:2363-2375.
18. Mihm MJ, Seifert JL, Coyle CM, Bauer JA: Diabetes related cardiomyopathy time dependent echocardiographic evaluation in an experimental rat model. Life Sci 2001;69:527-542.
19. Howarth FC, Qureshi MA: Characterisation of ventricular myocyte shortening after administration of streptozotocin to neonatal rats. Arch Physiol Biochem 2001;109:200-205.
20. Pogatsa G, Dubecz E: Effect of hyperglycaemia-induced hyperosmolality on heart function in the dog. Eur J Clin Invest 1979;9:147-150.
21. Sewdarsen M, Jialal I, Vythilingum S, Govender G, Rajput MC: Stress hyperglycaemia is a predictor of abnormal glucose tolerance in Indian patients with acute myocardial infarction. Diabetes Res 1987;6:47-49.
22. Oswald GA, Smith CCT, Betteridge DJ, Yudkin JS: Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed) 1986;293:917-922.
23. Van den Berghe G, Wouters P, Weekers F, Werwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-1367.
24. O'Flaherty L, Bouchier-Hayes DJ: Immunonutrition and surgical practice. Proc Nutr Soc 1999;58:831-837.
25. Franconi F, Bennardini F, Mattana A, Miceli M, Ciuti M, Mian M, Gironi A, Anichini R, Seghieri G: Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am J Clin Nutr 1995;61:1115-1119.
26. 2]taurine in healthy adult humans. Am J Physiol Endocrinol Metab 2004;287:E255-E262.
27. Watson RWG, Redmond HP, Bouchier-Hayes D: Taurine upregulates antimicrobial function of human inflammatory cells through a calcium dependent mechanism. Surg Forum 1994;45:679
28. Stapleton PP, Redmond HP, Bouchier-Hayes DJ: Myeloperoxidase (MPO) may mediate neutrophil adherence to the endothelium through upregulation of CD11b expressionan effect downregulated by taurine. Adv Exp Med Biol 1998;442:183.
29. Jacobsen JG, Smith LH: Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev 1968;48:424-511.
30. Huxtable RJ, Sebring LA: Cardiovascular actions of taurine; in Kuriyama K, Huxtable R, Iwata H (eds): Sulphur Amino Acids: Biochemical and Clinical Aspects. New York, Alan R. Liss, 1983, pp 5-37.
31. Nara Y, Yamori Y, Lovenberg W: Effects of dietary taurine on blood pressures in spontaneously hypertensive rats. Biochem Pharmacol 1978;27:2689-2692.
32. Azuma H, Ischikawa M, Sekizaki S: Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 1986;88:411-415.
33. Azuma J, Hasegawa H, Sawamura A: Therapy of congestive heart failure with orally administered taurine. Clin Ther 1983;5:398-408.
34. Raschke P, Massoudy P, Becker BF: Taurine protects the heart from neutrophil-induced reperfusion injury. Free Radic Biol Med 1995;19:461-471.
35. Satoh H, Sperelakis N: Review of some actions of taurine on ion channels of cardiac muscle cells and others. Gen Pharmacol 1998;30:451-463.
36. Satoh H: Cardioprotective actions of taurine against intracellular and extracellular calcium-induced effects. Adv Exp Med Biol 1994;359:181-196.
37. Qi B, Yamagami T, Naruse Y: Effects of taurine on depletion of erythrocyte membrane Na-K ATPase activity due to ozone exposure or cholesterol enrichment. J Nutr Sci Vitaminol 1995;41:627-634.
38. Fennessy F, Smith G, Kelly C, Bouchier-Hayes DJ: Taurine restores endothelial-dependent but not independent dysfunction in young smokers. Br J Surg 1998;85:1582.
39. Park E, Schuller-Levis G, Quinn MR: Taurine chloramines inhibits production of nitric oxide and TNF-α in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events. J Immunol 1995;154:4778-4784.
40. Hansen SH: The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev 2001;17:330-346.
41. Li C, Cao L, Zeng Q, Liu X, Zhang Y, Dai T, Hu D, Huang K, Wang Y, Wang X, Li D, Chen Z, Zhang J, Li Y, Sharma R: Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin II type 2 receptor expression. Cardiovasc Drugs Ther 2005;19:105-112.
42. Nakaya Y, Minami A, Harada N, Sakamoto S, Niwa Y, Ohnaka M: Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. Am J Clin Nutr 2000;71:54-58.
43. Haber AC, Lam TKT, Yu Z, Gupta N, Goh T, Bogdanovic E, Giacca A, Fantus GI: N acetylcysteine and taurine prevent hyperglycaemia-induced insulin resistance in vivo: possible role of oxidative stress. Am J Physiol Endocrinol Metab 2003;285:E744-E754.
44. Kamata K, Sugiura M, Kojima S, Kasuya Y: Restoration of endothelium-dependent relaxation in both hypercholesterolaemia and diabetes by chronic taurine. Eur J Pharmacol 1996;303:47-53.
45. Marcinkiewicz J, Grabowska A, Bereta J, Stelmaszynska T: Taurine chloramines, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators. J Leuco Biol 1995;58:667-674.
46. Ren J, Davidoff AJ: Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes. Am J Physiol 1997;272:148-158.
47. Adams III JE, Abendschein DR, Jaffe AS: Biochemical markers of myocardial injury: is MB creatine kinase the choice for the 1990's? Circulation 1993;88:750-763.
48. Collinson PO, Boa FG, Gaze DC: Measurement of cardiac troponins. Ann Clin Biochem 2001;38:423-449.